Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
2
×
cancer drugs
life sciences
national blog main
national top stories
roche
2
×
san francisco blog main
san francisco top stories
amgen
avapritinib
blueprint medicines
boston
capmatinib
clinical trials
cobimetinib
deals
eli lilly
europe blog main
europe top stories
gastrointestinal stromal tumors
genentech
indiana blog main
indiana top stories
investing
ipo
life science
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
revolution medicines
san francisco
sanofi
selpercatinib
the column group
third rock ventures
thyroid cancer
What
cancer
drug
medicines
2
×
address
approval
approves
blueprint
carries
certain
designed
despite
family
fda
genetic
hardest
hit
hottest
hunters
ipo
latest
pass
proteins
ras
reels
research
ret
revolution
signature
signatures
targeted
targeting
targets
therapy
Language
unset
Current search:
roche
×
cancer
×
medicines
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
